GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹1.96 Cr | ₹1.66 Cr | ₹1.30 Cr | ₹1.02 Cr | ₹0.98 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹1.96 Cr |
| Mar2024 | ₹1.66 Cr |
| Mar2023 | ₹1.30 Cr |
| Mar2022 | ₹1.02 Cr |
| Mar2021 | ₹0.98 Cr |
How is Deferred Tax Assets / Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.96 Cr | 17.91 | |
| Mar2024 | ₹1.66 Cr | 28.00 | |
| Mar2023 | ₹1.30 Cr | 26.95 | |
| Mar2022 | ₹1.02 Cr | 4.60 | |
| Mar2021 | ₹0.98 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹4,198.7 Cr | -3.6% | 2.7% | 18.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,428.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,426.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,603.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹111,604.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,775.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -3.6% |
2.7% |
18.4% |
| SENSEX | 3.7% |
2.2% |
-7.2% |
You may also like the below Video Courses